Domestic companies who threw their votes for AACR… Next-generation anticancer drug challenge
A domestic biopharmaceutical company is going to the American Association for Cancer Research annual conference (AACR 2023) to publicize the clinical data of new anti-cancer drugs being developed on the international stage. As AACR is considered the world’s largest international academic event in the field of oncology, we are looking at plans for technology export … Read more